Evaluation of Vaccines to Prevent Childhood Pneumonia: Lessons Relevant to Planning Tuberculosis Vaccine Trials
Open Access
- 1 June 2000
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 30 (Supplement) , S206-S209
- https://doi.org/10.1086/313863
Abstract
Bacterial pneumonia in children is usually caused by one of the two leading pathogens, Streptococcus pneumoniae (pneumococcus) and Haemophilus influeKeywords
This publication has 11 references indexed in Scilit:
- Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infantsThe Lancet, 1997
- Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in MalawiThe Lancet, 1996
- Variation in protection by BCG: implications of and for heterologous immunityThe Lancet, 1995
- The etiology of pneumonia in malnourished and well-nourished Gambian childrenThe Pediatric Infectious Disease Journal, 1994
- Protective Effect of BCG against Tuberculous Meningitis and Miliary Tuberculosis: A Meta-AnalysisInternational Journal of Epidemiology, 1993
- Epidemiology of Acute Lower Respiratory Tract Infections, Especially Those Due to Haemophilus influenzae Type b, in The Gambia, West AfricaThe Journal of Infectious Diseases, 1992
- The Efficacy in Navajo Infants of a Conjugate Vaccine Consisting ofHaemophilus influenzaeType b Polysaccharide andNeisseria meningitidisOuter-Membrane Protein ComplexNew England Journal of Medicine, 1991
- A Randomized, Prospective Field Trial of a Conjugate Vaccine in the Protection of Infants and Young Children against InvasiveHaemophilus influenzaeType b DiseaseNew England Journal of Medicine, 1990
- Etiology of severe pneumonia in children in developing countriesThe Pediatric Infectious Disease Journal, 1986